Global Dermatological Therapeutics Market
- MAR2978597
- 206 Pages
- September 2018
- Pharmaceuticals
Market Dynamics
A major driver in the field of dermatology is the growing market for cosmetic dermatology due to increased awareness and higher disposable income at hand, mostly driven by an aging population. Another factor is the provision of preventive care in case of skin cancer which is manageable if caught early. Also, the demand for dermatology is increasing owing to the increase in cases of skin cancer worldwide and an aging population. Another factor for growth is the increased expenditure on healthcare and increased health insurance coverage. The high cost of R&D and increasing cost of therapy are some of the restraints of the dermatological market.
Market Segmentation
Global Dermatological Therapeutics Market can be segmented on the basis of type, diagnostic procedures, therapeutic procedures, and geography. The segments of dermatological therapeutics market include acne, psoriasis, rosacea, atopic dermatitis, and alopecia. Acne captures the highest market segment.
Segments on the basis of diagnostic procedures include dermoscopy, patch testing, skin biopsy, culture, and prevalence. Segments on the basis of therapeutic procedures are Anti-infectives, Corticosteroids, Anti Psoriasis, Anti-acne, Topical and other Dermatological Drugs.
Regional/Geographic Analysis
On the basis of region, the market can be segmented into North America, Europe and Asia-Pacific. Countries that capture the market share are: USA, Mexico and Canada in the North America region, in the Europe region there are Germany, France, UK, Italy, Spain etc., and in the Asia-Pacific region major markets are India, China, South Korea, New Zealand and Australia.
Key Players
Some of the major players in the market include Johnson & Johnson, Dermik Laboratories Inc, Eisai Inc., Onset Therapeutics, Prime Pharmaceuticals Corp, AGI Dermatics, Allergan Inc, Summers Laboratories Inc, Valeant Pharmaceuticals International etc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Treatment Procedures, Product Launch Timeline, etc.)
7. Pricing Analysis
8. Market Dynamics
8.1. Macroeconomic Factors
8.2. Drivers
8.2.1. Supply Side
8.2.2. Demand Side
8.3. Restraints
8.4. Opportunities
9. R&D Status and Technology Overview
10. Global Dermatological Therapeutics Market Analysis, By Affected Area
10.1. Introduction
10.2. Prominent Trends
10.3. Regulatory Guidelines
10.4. Market Size and Analysis, By Affected Area
10.4.1. Skin
10.4.2. Hair
10.4.3. Nails
10.4.4. Mucous Membranes
10.5. Market Share Analysis and YoY Growth Rates, By Affected Area
11. Global Dermatological Therapeutics Market Analysis, By Treatment Type
11.1. Introduction
11.2. Prominent Trends
11.3. Regulatory Guidelines
11.4. Market Size and Analysis, By Treatment Type
11.4.1. General (Medical & Surgical)
11.4.1.1. Acne & Rosacea
11.4.1.2. Vitiligo
11.4.1.3. Psoriasis
11.4.1.4. Dermatitis & Eczema
11.4.1.5. Contagious Skin Diseases
11.4.1.6. Fungal Infections
11.4.1.7. Hair Disorders
11.4.1.8. Nail Problems
11.4.1.9. Other Skin Lesions
11.4.2. Skin Cancers
11.4.3. Pediatrics
11.4.4. Cosmetics
11.4.5. Dermatopathology
11.4.6. Others
11.5. Market Share Analysis and YoY Growth Rates, By Treatment Type
12. Global Dermatological Therapeutics Market Analysis, By Treatment Procedure
12.1. Introduction
12.2. Prominent Trends
12.3. Regulatory Guidelines
12.4. Market Size and Analysis, By Treatment Procedure
12.4.1. Biopsies
12.4.2. Chemical Peels
12.4.3. Cosmetic Injections
12.4.4. Cryotherapy
12.4.5. Dermabrasion
12.4.6. Excisions of Lesions
12.4.7. Hair Transplantation
12.4.8. Laser Surgery
12.4.9. Mohs Surgery
12.4.10. PUVA
12.4.11. Tumescent Liposuction
12.4.12. Vein Therapy
12.4.13. Dermatological Drugs
12.4.14. Others
12.5. Market Share Analysis and YoY Growth Rates, By Treatment Procedure
13. Global Dermatological Therapeutics Market Analysis, By Patient’s Age
13.1. Introduction
13.2. Prominent Trends
13.3. Regulatory Guidelines
13.4. Market Size and Analysis, By Patient’s Age
13.4.1. > 65
13.4.2. [40,60]
13.4.3. < 40
13.5. Market Share Analysis and YoY Growth Rates, By Patient’s Age
14. Global Dermatological Therapeutics Market Analysis, By Region
14.1. Introduction
14.2. Prominent Trends
14.3. Regulatory Guidelines
14.4. Market Size and Analysis, By Region
14.4.1. North America
14.4.2. Latin America
14.4.3. Europe
14.4.4. Asia Pacific
14.4.5. Middle East & Africa (MEA)
14.5. Market Share Analysis and YoY Growth Rates, By Region
15. North America Dermatological Therapeutics Market Analysis
15.1. Introduction
15.2. Prominent Trends
15.3. North America Dermatological Therapeutics Market Analysis, by Country
15.3.1. U.S.
15.3.2. Canada
15.4. North America Dermatological Therapeutics Market Size and Analysis, By Affected Area
15.4.1. Skin
15.4.2. Hair
15.4.3. Nails
15.4.4. Mucous Membranes
15.5. North America Dermatological Therapeutics Market Size and Analysis, By Treatment Type
15.5.1. General (Medical & Surgical)
15.5.1.1. Acne & Rosacea
15.5.1.2. Vitiligo
15.5.1.3. Psoriasis
15.5.1.4. Dermatitis & Eczema
15.5.1.5. Contagious Skin Diseases
15.5.1.6. Fungal Infections
15.5.1.7. Hair Disorders
15.5.1.8. Nail Problems
15.5.1.9. Other Skin Lesions
15.5.2. Skin Cancers
15.5.3. Pediatrics
15.5.4. Cosmetics
15.5.5. Dermatopathology
15.5.6. Others
15.6. North America Dermatological Therapeutics Market Size and Analysis, By Treatment Procedure
15.6.1. Biopsies
15.6.2. Chemical Peels
15.6.3. Cosmetic Injections
15.6.4. Cryotherapy
15.6.5. Dermabrasion
15.6.6. Excisions of Lesions
15.6.7. Hair Transplantation
15.6.8. Laser Surgery
15.6.9. Mohs Surgery
15.6.10. PUVA
15.6.11. Tumescent Liposuction
15.6.12. Vein Therapy
15.6.13. Dermatological Drugs
15.6.14. Others
15.7. North America Dermatological Therapeutics Market Size and Analysis, By Patient’s Age
15.7.1. > 65
15.7.2. [40,60]
15.7.3. < 40
15.8. North America Dermatological Therapeutics Market Share Analysis and YoY Growth Rates
15.8.1. By Country
15.8.2. By Affected Area
15.8.3. By Treatment Type
15.8.4. By Treatment Procedure
15.8.5. By Patient’s Age
15.8.6. By Oil Affected Area
15.8.7. By Sales Channel
16. Latin America Dermatological Therapeutics Market Analysis
16.1. Introduction
16.2. Prominent Trends
16.3. Latin America Dermatological Therapeutics Market Analysis, by Country
16.3.1. Mexico
16.3.2. Brazil
16.3.3. Others
16.4. Latin America Dermatological Therapeutics Market Size and Analysis, By Affected Area
16.4.1. Skin
16.4.2. Hair
16.4.3. Nails
16.4.4. Mucous Membranes
16.5. Latin America Dermatological Therapeutics Market Size and Analysis, By Treatment Type
16.5.1. General (Medical & Surgical)
16.5.1.1. Acne & Rosacea
16.5.1.2. Vitiligo
16.5.1.3. Psoriasis
16.5.1.4. Dermatitis & Eczema
16.5.1.5. Contagious Skin Diseases
16.5.1.6. Fungal Infections
16.5.1.7. Hair Disorders
16.5.1.8. Nail Problems
16.5.1.9. Other Skin Lesions
16.5.2. Skin Cancers
16.5.3. Pediatrics
16.5.4. Cosmetics
16.5.5. Dermatopathology
16.5.6. Others
16.6. Latin America Dermatological Therapeutics Market Size and Analysis, By Treatment Procedure
16.6.1. Biopsies
16.6.2. Chemical Peels
16.6.3. Cosmetic Injections
16.6.4. Cryotherapy
16.6.5. Dermabrasion
16.6.6. Excisions of Lesions
16.6.7. Hair Transplantation
16.6.8. Laser Surgery
16.6.9. Mohs Surgery
16.6.10. PUVA
16.6.11. Tumescent Liposuction
16.6.12. Vein Therapy
16.6.13. Dermatological Drugs
16.6.14. Others
16.7. Latin America Dermatological Therapeutics Market Size and Analysis, By Patient’s Age
16.7.1. > 65
16.7.2. [40,60]
16.7.3. < 40
16.8. Latin America Dermatological Therapeutics Market Share Analysis and YoY Growth Rates
16.8.1. By Country
16.8.2. By Affected Area
16.8.3. By Treatment Type
16.8.4. By Treatment Procedure
16.8.5. By Patient’s Age
16.8.6. By Oil Affected Area
16.8.7. By Sales Channel
17. Europe Dermatological Therapeutics Market Analysis
17.1. Introduction
17.2. Prominent Trends
17.3. Europe Dermatological Therapeutics Market Analysis, by Country
17.3.1. Germany
17.3.2. U.K.
17.3.3. Spain
17.3.4. France
17.3.5. Italy
17.3.6. Russia
17.3.7. Others
17.4. Europe Dermatological Therapeutics Market Size and Analysis, By Affected Area
17.4.1. Skin
17.4.2. Hair
17.4.3. Nails
17.4.4. Mucous Membranes
17.5. Europe Dermatological Therapeutics Market Size and Analysis, By Treatment Type
17.5.1. General (Medical & Surgical)
17.5.1.1. Acne & Rosacea
17.5.1.2. Vitiligo
17.5.1.3. Psoriasis
17.5.1.4. Dermatitis & Eczema
17.5.1.5. Contagious Skin Diseases
17.5.1.6. Fungal Infections
17.5.1.7. Hair Disorders
17.5.1.8. Nail Problems
17.5.1.9. Other Skin Lesions
17.5.2. Skin Cancers
17.5.3. Pediatrics
17.5.4. Cosmetics
17.5.5. Dermatopathology
17.5.6. Others
17.6. Europe Dermatological Therapeutics Market Size and Analysis, By Treatment Procedure
17.6.1. Biopsies
17.6.2. Chemical Peels
17.6.3. Cosmetic Injections
17.6.4. Cryotherapy
17.6.5. Dermabrasion
17.6.6. Excisions of Lesions
17.6.7. Hair Transplantation
17.6.8. Laser Surgery
17.6.9. Mohs Surgery
17.6.10. PUVA
17.6.11. Tumescent Liposuction
17.6.12. Vein Therapy
17.6.13. Dermatological Drugs
17.6.14. Others
17.7. Europe Dermatological Therapeutics Market Size and Analysis, By Patient’s Age
17.7.1. > 65
17.7.2. [40,60]
17.7.3. < 40
17.8. Europe Dermatological Therapeutics Market Share Analysis and YoY Growth Rates
17.8.1. By Country
17.8.2. By Affected Area
17.8.3. By Treatment Type
17.8.4. By Treatment Procedure
17.8.5. By Patient’s Age
17.8.6. By Oil Affected Area
17.8.7. By Sales Channel
18. Asia Pacific Dermatological Therapeutics Market Analysis
18.1. Introduction
18.2. Prominent Trends
18.3. Asia Pacific Dermatological Therapeutics Market Analysis, by Country
18.3.1. India
18.3.2. China
18.3.3. Australia & New Zealand
18.3.4. Japan
18.3.5. Others
18.4. Asia Pacific Dermatological Therapeutics Market Size and Analysis, By Affected Area
18.4.1. Skin
18.4.2. Hair
18.4.3. Nails
18.4.4. Mucous Membranes
18.5. Asia Pacific Dermatological Therapeutics Market Size and Analysis, By Treatment Type
18.5.1. General (Medical & Surgical)
18.5.1.1. Acne & Rosacea
18.5.1.2. Vitiligo
18.5.1.3. Psoriasis
18.5.1.4. Dermatitis & Eczema
18.5.1.5. Contagious Skin Diseases
18.5.1.6. Fungal Infections
18.5.1.7. Hair Disorders
18.5.1.8. Nail Problems
18.5.1.9. Other Skin Lesions
18.5.2. Skin Cancers
18.5.3. Pediatrics
18.5.4. Cosmetics
18.5.5. Dermatopathology
18.5.6. Others
18.6. Asia Pacific Dermatological Therapeutics Market Size and Analysis, By Treatment Procedure
18.6.1. Biopsies
18.6.2. Chemical Peels
18.6.3. Cosmetic Injections
18.6.4. Cryotherapy
18.6.5. Dermabrasion
18.6.6. Excisions of Lesions
18.6.7. Hair Transplantation
18.6.8. Laser Surgery
18.6.9. Mohs Surgery
18.6.10. PUVA
18.6.11. Tumescent Liposuction
18.6.12. Vein Therapy
18.6.13. Dermatological Drugs
18.6.14. Others
18.7. Asia Pacific Dermatological Therapeutics Market Size and Analysis, By Patient’s Age
18.7.1. > 65
18.7.2. [40,60]
18.7.3. < 40
18.8. Asia Pacific Dermatological Therapeutics Market Share Analysis and YoY Growth Rates
18.8.1. By Country
18.8.2. By Affected Area
18.8.3. By Treatment Type
18.8.4. By Treatment Procedure
18.8.5. By Patient’s Age
18.8.6. By Oil Affected Area
18.8.7. By Sales Channel
19. Middle East and Africa (MEA) Dermatological Therapeutics Market Analysis
19.1. Introduction
19.2. Prominent Trends
19.3. Middle East and Africa Dermatological Therapeutics Market Analysis, by Country
19.3.1. GCC countries
19.3.2. South Africa
19.3.3. North Africa
19.3.4. Rest of Middle East and Africa
19.4. Middle East and Africa (MEA) Dermatological Therapeutics Market Size and Analysis, By Affected Area
19.4.1. Skin
19.4.2. Hair
19.4.3. Nails
19.4.4. Mucous Membranes
19.5. Middle East and Africa (MEA) Dermatological Therapeutics Market Size and Analysis, By Treatment Type
19.5.1. General (Medical & Surgical)
19.5.1.1. Acne & Rosacea
19.5.1.2. Vitiligo
19.5.1.3. Psoriasis
19.5.1.4. Dermatitis & Eczema
19.5.1.5. Contagious Skin Diseases
19.5.1.6. Fungal Infections
19.5.1.7. Hair Disorders
19.5.1.8. Nail Problems
19.5.1.9. Other Skin Lesions
19.5.2. Skin Cancers
19.5.3. Pediatrics
19.5.4. Cosmetics
19.5.5. Dermatopathology
19.5.6. Others
19.6. Middle East and Africa (MEA) Dermatological Therapeutics Market Size and Analysis, By Treatment Procedure
19.6.1. Biopsies
19.6.2. Chemical Peels
19.6.3. Cosmetic Injections
19.6.4. Cryotherapy
19.6.5. Dermabrasion
19.6.6. Excisions of Lesions
19.6.7. Hair Transplantation
19.6.8. Laser Surgery
19.6.9. Mohs Surgery
19.6.10. PUVA
19.6.11. Tumescent Liposuction
19.6.12. Vein Therapy
19.6.13. Dermatological Drugs
19.6.14. Others
19.7. Middle East and Africa (MEA) Dermatological Therapeutics Market Size and Analysis, By Patient’s Age
19.7.1. > 65
19.7.2. [40,60]
19.7.3. < 40
19.8. Middle East and Africa (MEA) Dermatological Therapeutics Market Share Analysis and YoY Growth Rates
19.8.1. By Country
19.8.2. By Affected Area
19.8.3. By Treatment Type
19.8.4. By Treatment Procedure
19.8.5. By Patient’s Age
19.8.6. By Oil Affected Area
19.8.7. By Sales Channel
20. Industry Structure
20.1. Porters Five Forces Analysis
20.1.1. Bargaining Power of Suppliers
20.1.2. Bargaining Power of Buyers
20.1.3. Threat of New Entrants
20.1.4. Threat of Substitute Products and Services
20.1.5. Internal Rivalry
20.2. Supply Chain Analysis and Profitability Margins
20.3. Market Share Analysis
20.4. Strategic Analysis
20.4.1. Competitive Strategies
20.4.2. Mergers & Acquisitions Activity
20.4.3. Co-operative Agreements
20.5. Critical Success Factor (CSF) Analysis (Technology & Manufacturing, Design & Features, Brand Reputation, Distribution Network, Marketing)
20.6. Company Profiles (Overview, Product/Service Details, Geographic Scope, Financials, Strategic Intent & Approach, Core Competencies & Competitive Advantage and Key developments)
20.6.1. Johnson & Johnson
20.6.2. Dermik Laboratories Inc
20.6.3. Eisai Inc
20.6.4. Onset Therapeutics
20.6.5. Prime Pharmaceuticals Corp
20.6.6. AGI Dermatics
20.6.7. Allergan Inc
20.6.8. Summers Laboratories Inc
20.6.9. Valeant Pharmaceuticals International
20.6.10. Chester Valley Pharmaceuticals Inc
20.6.11. Ferndale Laboratories Inc
20.6.12. Genentech Inc
20.6.13. Medicis Pharmaceutical Corp
20.6.14. Bayer AG
20.6.15. Novartis Pharmaceuticals Corporation
21. Prognosis for the Future
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
